New prostate cancer treatment strategy tested against standard care
NCT ID NCT07237269
Summary
This study compares two different hormone therapy approaches, both combined with radiation, for men with prostate cancer that has spread to nearby lymph nodes. Researchers want to see if adding two extra medications (abiraterone and prednisone) to standard hormone therapy improves cancer control over 5 years compared to standard hormone therapy alone. The trial will also track side effects and quality of life in 140 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.